Research Overview
The Brain Imaging–Disease Risk Atlas project aims to uncover how structural and functional features of the human brain relate to the risk of developing diseases across multiple organ systems. Leveraging multimodal magnetic resonance imaging (MRI) and linked hospital records from ~6,0000 participants in the UK Biobank (Application No. 194287), this work systematically mapped associations between 505 brain imaging-derived phenotypes (IDPs) and 738 incident diseases, establishing the largest population-based atlas of brain–disease relationships to date.
Brain imaging metrics were derived from three core modalities—T1-weighted structural MRI, diffusion MRI, and resting-state functional MRI (rs-fMRI)—and included measures of cortical thickness, cortical surface area, cortical volume, subcortical volume, white-matter integrity (fractional anisotropy [FA] and mean diffusivity [MD]), and functional connectivity (Nodes and Edges). Disease outcomes were defined using hospital inpatient records linked to the National Health Service (NHS) and harmonized according to the Phecode Map v1.2, providing 738 clinically meaningful phenotypes across 15 disease chapters.
Using a phenome-wide association study (PheWAS) framework based on Cox proportional hazards models, we identified 1,491 significant brain–disease pairs after stringent Bonferroni correction. All PheWAS results are available through this open-access platform, enabling interactive exploration of brain–body associations and providing a foundation for mechanistic research, precision risk assessment, and the development of neuromodulatory strategies targeting systemic health.
You can access and download the result information of interest by selecting “By Brain IDP” or “By Disease” from the options on the left panel. Details about the project and methods can be found in our paper.
If you use any results, figures, or insights from this website, please cite both the associated paper and this website.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.